Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort
Peter S. Kirk(University of Washington), Jonathan L. Wright(Seattle University), Laura S. Mertens(Oncode Institute), Niels-Erik Jacobson(University of Alberta), Maria Carmen Mir(Fundación Instituto Valenciano de Oncología), Andrew C. Thorpe(Freeman Hospital), Évanguelos Xylinas(NewYork–Presbyterian Hospital), Peter Black(Southwestern Medical Center), Wassim Kassouf(McGill University), Petros Grivas(Seattle Cancer Care Alliance), Todd M. Morgan(University of Michigan), Homayoun Zargar(University of British Columbia), Philippe E. Spiess(Moffitt Cancer Center), Yair Lotan(Southwestern Medical Center), Srikala S. Sridhar(Princess Margaret Cancer Centre), Siamak Daneshmand(Unknown), Adrian Fairey(University of Alberta), Michael S. Cookson(University of Oklahoma Health Sciences Center), Jonathan S. McGrath(Royal Devon & Exeter NHS Foundation Trust), Nikhil Vasdev(University of Hertfordshire), Jay B. Shah(The University of Texas MD Anderson Cancer Center), Scott North, Daniel A. Barocas(Vanderbilt University Medical Center), Trinity J. Bivalacqua(University of Pennsylvania), Shahrokh F. Shariat(Universitätszahnklinik Wien), Laura‐Maria Krabbe, Marc Dall’Era(University of California, Davis), Andrew J. Stephenson(Republic of Korea Army), Jorge A. García(Cleveland Clinic), Bas W.G. van Rhijn(The Netherlands Cancer Institute), Jeff M. Holzbeierlein(University of Kansas), Jeffrey S. Montgomery(Ann Arbor Center for Independent Living), Jonathan Aning(Royal Devon and Exeter Hospital), Evan Y. Yu, Colin P. Dinney(The University of Texas MD Anderson Cancer Center)
Cited by 10
Related Papers
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|2.2k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k